Download Files:
Products Details
Product Description
– CDK7-IN-13 is a potent inhibitor of CDK7. CDK7-IN-13 is a pyrimidinyl derivative compound. CDK7-IN-13 has the potential for the research of various cancers, especially the cancer with transcriptional dysregulation (extracted from patent CN114249712A, compound 1)[1].
Web ID
– HY-147597
Shipping
– Room temperature
Applications
– Cancer-Kinase/protease
Molecular Formula
– C20H23F3N6OS
References
– [1]Guanpeng Qiu, et al. Pyrimidinyl derivatives, method for the production thereof and use thereof. Patent CN114249712A.
CAS Number
– 2765676-20-6
Molecular Weight
– 452.50
SMILES
– CS(C)(=O)=NC1=CC=CC2=C1NC=C2C3=NC(N[C@H]4CCCNC4)=NC=C3C(F)(F)F
Clinical Information
– No Development Reported
Research Area
– Cancer
Solubility
– 10 mM in DMSO
Target
– CDK
Pathway
– Cell Cycle/DNA Damage
Product type
– Reference compound
Disclaimer: All products are for Research use only unless clearly stated otherwise on the product datasheet. Datasheets provided on the website are drafts for reference purpose only and you are requested to always refer to the hard copy included in the kit for your experimentation. Agdia Products are available for delivery only in Canada.
